Physician perceptions and use of reduced-dose direct oral anticoagulants for extended phase venous thromboembolism treatment

Authors

Danielle Groat, Intermountain Medical Center
Karlyn A Martin, Northwestern University
Rachel P Rosovsky, Harvard University
Kristen M Sanfilippo, Washington University School of Medicine in St. Louis
Manila Gaddh, Emory University
Lisa Baumann Kreuziger, Versiti
M Elaine Eyster, Penn State
Scott C Woller, University of Utah
Venous thromboEmbolism Network US (VENUS) VTE Treatment, Anticoagulation Management Group

Journal

Research and Practice in Thrombosis and Haemostasis

Publication Date

5-1-2022

Volume

6

Issue

4

First Page

e12740

Document Type

Open Access Publication

DOI

10.1002/rth2.12740

Rights and Permissions

Groat, D, Martin, KA, Rosovsky, RP, et al. Physician perceptions and use of reduced-dose direct oral anticoagulants for extended phase venous thromboembolism treatment. Res Pract Thromb Haemost. 2022; 6:e12740. doi:10.1002/rth2.12740 © 2022 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis (ISTH). This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Recommended Citation

Groat, Danielle; Martin, Karlyn A; Rosovsky, Rachel P; Sanfilippo, Kristen M; Gaddh, Manila; Kreuziger, Lisa Baumann; Eyster, M Elaine; Woller, Scott C; and Venous thromboEmbolism Network US (VENUS) VTE Treatment, Anticoagulation Management Group, "Physician perceptions and use of reduced-dose direct oral anticoagulants for extended phase venous thromboembolism treatment." Research and Practice in Thrombosis and Haemostasis. 6, 4. e12740 (2022).
https://digitalcommons.wustl.edu/oa_4/40